A Product, News and Clinical Update for the Cardiac Catheterization Laboratory Specialist
  ||  Home  ||  Editorial Board  ||  Classified  ||  Media Kit  ||  Subscriptions  ||  E-News   ||  
Cath Lab Digest
Current Issue
Archives
Clinical Events Calendar
Webcasts & Symposia
Classified Ads
Cath Lab News
CME
About Us
Author Guidelines
Search Articles
Editor's Update
Media Kit
Classified & Recruitment Media Kit

Cath Lab Topics
Stents
Cardiac Imaging
Vessel Closure
Pharmacology
Genomics
Embolic Protection
Cath Lab Management

Disease States
Acute Coronary Syndromes
Chronic Total Occlusions
Vulnerable Plaque
Patent Foramen Ovale
Aortic Valve Replacement
Myocardial Infarction
Stroke
Heart Failure
Peripheral Arterial Disease
Peripheral Venous Disease
Cardiac Arrhythmia
Aneurysm

Beta Blockers

Beta blockers play many roles in the treatment and control of various conditions such as angina, heart failure, high blood pressure, and irregular heartbeats, to name only a few. There are many types of beta blockers available to doctors, and Cath Lab Digest delves deeper into the catheterization processes and cardiac health issues involving beta blockers.

Clinical and Industry News
Clinical and Industry News Industry News: Clinical and Industry News - Lifestyle Changes Can Quickly Reverse Heart Risks In less than a month, individuals can reverse serious heart disease risk factors by making significant lifestyle changes, researchers are reporting. Amiodarone plus beta-blocker significantly reduced (73 percent) the risk of shock compared with beta-blocker alone and sotalol (57 percent reduction). The researchers found that sibling CVD was associated with a 55 percent ...



News from the American College of Cardiology meeting (Part II)
March 7?10, 2004 New Orleans, Louisiana

Dr. Moses said DIRECT trial findings for in-stent late lumen loss compared favorably with those documented in the SIRIUS trial, which used balloon pre-dilatation (0.18 mm for DIRECT patients versus 0.17 mm for SIRIUS patients). In-stent and in-lesion late loss were 0.20 mm for the insulin-dependent DIRECT trial patients compared with 0.33 mm in-stent late loss and 0.58 mm in-lesion late loss for insulin-dependent SIRIUS trial patients. PAVE and DINAMIT: Clinical Trial Results Evaluate the ...



Letters to the Editor
Cath Lab Digest 2004;12(10):39-43. Dear Editor: When I started working cath lab, the MD would pull the balloon and hold for the first 5 minutes and then the RN would take over. Vicki Walston, BSN, RN, VAMC, Minneapolis, MN, walston85@msn.com Re: Rasmussen MR. ?Acute Myocardial Infarction Drug Management.? Ken Gorski, RN, RCIS, FSICP, Cath Lab Digest Editorial Board Member Sones Cardiac Catheterization Labs, The Cleveland Clinic Foundation Cleveland, OH, gorskik@ccf.org The December article ...



News from the AHA cont.
- Study Shows Impact of CoregĀ® (carvedilol) on Cardiovascular Risk Factors in Patients With Diabetes and Hypertension Beta-blocker CoregĀ® (carvedilol) may provide advantages in patients with diabetes and hypertension, according to study results released by GlaxoSmithKline. Blood Pressure: Patients on carvedilol reached protocol specified blood pressure goals at a mean daily dose of 35 mg; patients receiving metoprolol tartrate required a mean daily dose of 256 mg to reach protocol-specified ...



News from the American College of Cardiology meeting (Part I)
March 7?10, 2004 New Orleans, Louisiana

The first was whether statins would be effective in heart attack patients in a hospital setting. Doctors at the hospitals use standardized forms for ordering treatment for their heart attack patients. Heart Patients Undertreated in ER, Despite New Tests Many heart attack patients admitted to the emergency room are going without drugs or surgical procedures that could extend their lives, despite blood test results indicating a need for more aggressive therapy, researchers report.



Clinical and Industry News
? The project is made possible by reverse engineering. After treatment, patients?



Strategies for Managing the Special Patient in the Catheterization Laboratory
The following article will provide an overview of allergies, anaphylaxis and tips for identifying and treating patients in the cath lab who are at risk for an allergic reaction. Special concerns surrounding the pregnant patient in the lab will be discussed. Finally, informed consent will be addressed, especially as it concerns patients who are not competent or are not able to give consent, such as minors, patients with dementia, and patients who need emergency treatment.



Improved Efficiency in Acute Myocardial Infarction Care Through Commitment to Emergency Department Initiated Primary PCI
ABSTRACT: Study objective. Methods. Establishing the clinical and business case for process change.



Systemic Anaphylactoid Reactions to Iodinated Contrast Media During Cardiac Catheterization Procedures: Guidelines for prevention, diagnosis, and treatment
This article is reprinted with permission from Catheterization and Cardiovascular Diagnosis 1995;34:99-104.



Medical Management is the Only Rational Approach
?Early conservative treatment is not bad. We can effectively manage the majority of unstable angina cases with aggressive medical treatment.?



 






On Demand Medical Education
CME Activities
Achieving Successful Hemostasis: Prevent RSI Through Mechanical Compression
Evidence-Based Approach to Atrial Fibrillation
TIPS Procedure: Improved Outcomes Through Improved Solutions
more CME activities




About HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP's products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holding LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP's products and services at www.hmpcommunications.com.


Interventional Cardiology© 2008 HMP Communications | Privacy Policy/Copyright | Contact Us

Your HeartECPNInslime